Who Buys Vinblastine from India — 244 Importers Behind a $750.1K Market
India's vinblastine import market is served by 244 active buyers who collectively imported $750.1K across 573 shipments. HIRAD PHRAMED (IRAN) leads with a 5.7% market share, followed by EXP CODE and GLORINCOR PHARMACEUTICALS OOO. The top 5 buyers together control 19.3% of total import value, reflecting a moderately competitive buyer landscape.
Top Vinblastine Importers — Ranked by Import Value
HIRAD PHRAMED (IRAN) is the leading vinblastine importer from India, holding a 5.7% share of the $750.1K market across 573 shipments from 244 buyers. The top 5 buyers — HIRAD PHRAMED (IRAN), EXP CODE (POLAND), GLORINCOR PHARMACEUTICALS OOO (BELARUS), LABORATORIOS KAMPAR S.A. (CHILE), IMPORT MANAGER CLIENT CODE (LEBANON) — collectively control 19.3% of total import value.
Top Vinblastine Buyers & Importers
Ranked by import value · 244 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | HIRAD PHRAMEDIRAN VINB SPAL 10 | $42.4K | 5 | 5.7% |
| 2 | EXP CODEPOLAND VINBLASTINE SULPHATE INJ 10MG | $28.9K | 5 | 3.9% |
| 3 | GLORINCOR PHARMACEUTICALS OOOBELARUS PHARMA PRODUCT-VINBLASTINE FOR INJECTIONVINBLASTINE INJECTION BP 5MG/5ML (EACH VVINBLASTINE INJECTION BP 5MG/5ML | $28.6K | 5 | 3.8% |
| 4 | LABORATORIOS KAMPAR S.A.CHILE VINBLASTINE SULFATE FOR INJECTION USP 10MGVINBLASTINE SULFATE FOR INJECTION USP 10MG VINB SPAL 10 | $26.6K | 5 | 3.5% |
| 5 | IMPORT MANAGER CLIENT CODELEBANON VINBLASTINE SULFATE FOR INJECTION USP 10MG/VIAL- CHEMOBLASTVINBLASTINE SULPHATE INJ 10MGVINBLASTINE SULPHATE INJECTION 10MG/10ML CHEMOBLAST | $18.1K | 5 | 2.4% |
| 6 | ETHIOPIAN PHARMACEUTICALS SUPPLY AGKENYA VIVABLASTIN (VINBLASTINE SULFATE FOR INJVINBLASTINE SULPHATE INJECTION 10MG/10MLVINBLASTINE 10MG INJ | $14.1K | 5 | 1.9% |
| 7 | PHARMACEUTICAL DISTOLOZA S.A.PERU VILBAN 10MG (VINBLASTINE SULFATE FOR INJVIVABLASTIN (VINBLASTINE SULFATE FOR INJPHARMA PRODUCT-VINBLASTINE FOR INJECTION | $11.2K | 5 | 1.5% |
| 8 | PEOPLE'S BANKSRI LANKA PHARMA PRODUCT-UNIBLASTINPHARMACEUTICAL MEDICINAL PRODUCTSVINBLASTINE SULPHATE SOLUTION FOR INJECT | $10.7K | 5 | 1.4% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Vinblastine — and from which countries?
Flow of Vinblastine exports from India: each country's share and the named importers behind the numbers
Vinblastine — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Colombia
Colombia emerges as the first largest importing country, achieving a total trade value of $72.2K through 0 shipments. This represents a market share of 9.6% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Colombia demonstrates strong market positioning with an average shipment value of $72.2K, indicating premium pricing strategy compared to the market average of $1.3K.
Colombia is a key market for Vinblastine imports, representing 9.6% of total trade value.
2Iran
Iran emerges as the second largest importing country, achieving a total trade value of $70.0K through 2 shipments. This represents a market share of 9.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Iran has a diverse importer base, with their top importers including:
• HIRAD PHRAMED - $42.4K (60.7% of country's total business)
Key Insight: Iran demonstrates strong market positioning with an average shipment value of $35.0K, indicating premium pricing strategy compared to the market average of $1.3K.
Iran is a key market for Vinblastine imports, representing 9.3% of total trade value.
3Poland
Poland emerges as the third largest importing country, achieving a total trade value of $59.7K through 4 shipments. This represents a market share of 8.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Poland has a diverse importer base, with their top importers including:
• EXP CODE - $28.9K (48.4% of country's total business)
Key Insight: Poland demonstrates strong market positioning with an average shipment value of $14.9K, indicating premium pricing strategy compared to the market average of $1.3K.
Poland is a key market for Vinblastine imports, representing 8.0% of total trade value.
4Thailand
Thailand emerges as the fourth largest importing country, achieving a total trade value of $59.3K through 0 shipments. This represents a market share of 7.9% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Thailand demonstrates strong market positioning with an average shipment value of $59.3K, indicating premium pricing strategy compared to the market average of $1.3K.
Thailand is a key market for Vinblastine imports, representing 7.9% of total trade value.
5Venezuela
Venezuela emerges as the fifth largest importing country, achieving a total trade value of $48.1K through 0 shipments. This represents a market share of 6.4% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Venezuela demonstrates strong market positioning with an average shipment value of $48.1K, indicating premium pricing strategy compared to the market average of $1.3K.
Venezuela is a key market for Vinblastine imports, representing 6.4% of total trade value.
Buyer Segment Analysis
TransData Nexus Vinblastine buyer market intelligence
1Buyer Segment Analysis
The importation of Vinblastine from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like HIRAD PHRAMED in Iran and GLORINCOR PHARMACEUTICALS OOO in Belarus function as intermediaries, procuring Vinblastine in bulk to supply to healthcare providers. Their order patterns are characterized by large volumes and regular intervals to maintain a steady supply chain.
- Hospital Groups: Organizations such as LABORATORIOS KAMPAR S.A. in Chile and PHARMACEUTICAL DISTOLOZA S.A. in Peru represent hospital networks that import Vinblastine directly for patient treatment. Their purchasing is driven by patient demand and treatment protocols, leading to variable order sizes and frequencies.
- Government Procurement Agencies: Entities like the ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY in Kenya are responsible for national healthcare procurement. They often engage in tender-based purchasing, resulting in large, periodic orders aligned with government healthcare initiatives and budget cycles.
- Re-exporters: Companies such as IMPORT MANAGER CLIENT CODE in Lebanon may act as re-exporters, importing Vinblastine for redistribution to neighboring regions. Their buying behavior includes bulk purchases with a focus on market demand and regional distribution strategies.
- Contract Manufacturers: While not explicitly listed among the top buyers, contract manufacturers procure Vinblastine as an active pharmaceutical ingredient (API) for formulation into finished products. Their orders are typically large and scheduled to align with production cycles and client demands.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Vinblastine buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Vinblastine from India, the import regulations are as follows:
1. Colombia:
2. Iran:
3. Poland:
4. Thailand:
5. Venezuela:
Navigating these regulatory landscapes requires thorough preparation and compliance with each country's specific requirements to ensure successful market entry.
Demand Drivers & Market Opportunity
TransData Nexus Vinblastine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Vinblastine in importing countries is influenced by several key factors:
- Disease Prevalence: Vinblastine is primarily used in the treatment of various cancers, including Hodgkin's lymphoma and testicular cancer. The prevalence of these conditions in countries like Colombia, Iran, and Thailand drives the need for effective chemotherapy agents.
- Government Healthcare Programs: Many countries have national health initiatives aimed at improving cancer care. For instance, Thailand's Universal Coverage Scheme provides access to essential medicines, including chemotherapy agents, thereby increasing demand for Vinblastine.
- WHO Essential Medicines List (EML) Procurement: Vinblastine is listed on the WHO Model List of Essential Medicines, guiding countries in their procurement decisions. This inclusion underscores its importance and encourages its availability in national healthcare systems.
- Tender-Based Purchasing: Government and international organizations often procure medicines through tenders to ensure cost-effectiveness and supply security. The presence of 244 buyers across 96 countries, as per TransData Nexus data, indicates a robust market for Vinblastine facilitated by such procurement mechanisms.
These factors collectively contribute to a sustained and growing demand for Vinblastine, presenting significant market opportunities for suppliers.
Common Questions — Vinblastine Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest vinblastine buyer importing from India?
Based on import volume and value, HIRAD PHRAMED (IRAN) leads with $42.4K in imports and a 5.7% market share — the highest of any single vinblastine importer. EXP CODE (POLAND) and GLORINCOR PHARMACEUTICALS OOO (BELARUS) are the next largest buyers.
QHow many companies buy vinblastine from India?
There are 244 active vinblastine buyers importing from India, with a combined market of $750.1K across 573 shipments to 96 countries. The top 5 buyers hold 19.3% of total import value, while the remaining 239 buyers handle the other 80.7%.
QWhich countries import the most vinblastine from India?
The top importing countries for vinblastine from India are Colombia (9.6%), Iran (9.3%), Poland (8.0%), Thailand (7.9%), Venezuela (6.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of vinblastine, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for vinblastine from India?
The average import transaction value for vinblastine from India is $1.3K, with an average unit price of $3.98 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Vinblastine buyer market intelligence
1Buyer Segment Analysis
The importation of Vinblastine from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like HIRAD PHRAMED in Iran and GLORINCOR PHARMACEUTICALS OOO in Belarus function as intermediaries, procuring Vinblastine in bulk to supply to healthcare providers. Their order patterns are characterized by large volumes and regular intervals to maintain a steady supply chain.
- Hospital Groups: Organizations such as LABORATORIOS KAMPAR S.A. in Chile and PHARMACEUTICAL DISTOLOZA S.A. in Peru represent hospital networks that import Vinblastine directly for patient treatment. Their purchasing is driven by patient demand and treatment protocols, leading to variable order sizes and frequencies.
- Government Procurement Agencies: Entities like the ETHIOPIAN PHARMACEUTICALS SUPPLY AGENCY in Kenya are responsible for national healthcare procurement. They often engage in tender-based purchasing, resulting in large, periodic orders aligned with government healthcare initiatives and budget cycles.
- Re-exporters: Companies such as IMPORT MANAGER CLIENT CODE in Lebanon may act as re-exporters, importing Vinblastine for redistribution to neighboring regions. Their buying behavior includes bulk purchases with a focus on market demand and regional distribution strategies.
- Contract Manufacturers: While not explicitly listed among the top buyers, contract manufacturers procure Vinblastine as an active pharmaceutical ingredient (API) for formulation into finished products. Their orders are typically large and scheduled to align with production cycles and client demands.
Understanding these segments is crucial for tailoring marketing strategies and supply chain logistics to meet the specific needs and behaviors of each buyer type.
Country-Specific Import Regulations
TransData Nexus Vinblastine buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries of Vinblastine from India, the import regulations are as follows:
1. Colombia:
2. Iran:
3. Poland:
4. Thailand:
5. Venezuela:
Navigating these regulatory landscapes requires thorough preparation and compliance with each country's specific requirements to ensure successful market entry.
Demand Drivers & Market Opportunity
TransData Nexus Vinblastine buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Vinblastine in importing countries is influenced by several key factors:
- Disease Prevalence: Vinblastine is primarily used in the treatment of various cancers, including Hodgkin's lymphoma and testicular cancer. The prevalence of these conditions in countries like Colombia, Iran, and Thailand drives the need for effective chemotherapy agents.
- Government Healthcare Programs: Many countries have national health initiatives aimed at improving cancer care. For instance, Thailand's Universal Coverage Scheme provides access to essential medicines, including chemotherapy agents, thereby increasing demand for Vinblastine.
- WHO Essential Medicines List (EML) Procurement: Vinblastine is listed on the WHO Model List of Essential Medicines, guiding countries in their procurement decisions. This inclusion underscores its importance and encourages its availability in national healthcare systems.
- Tender-Based Purchasing: Government and international organizations often procure medicines through tenders to ensure cost-effectiveness and supply security. The presence of 244 buyers across 96 countries, as per TransData Nexus data, indicates a robust market for Vinblastine facilitated by such procurement mechanisms.
These factors collectively contribute to a sustained and growing demand for Vinblastine, presenting significant market opportunities for suppliers.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 244 global importers of Vinblastine identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 573 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 96 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
573 Verified Shipments
244 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists